Clinical Significance
- Determining eligibility for targeted therapies like Trastuzumab.
- Assessing tumor aggressiveness and growth rate.
- Developing a personalized treatment plan based on molecular characteristics.
Book HER2 Neu IHC Test in Saudi Arabia | Lahalak Medical Platform
This precise IHC test determines HER2 protein expression levels on cancer cell surfaces, enabling oncologists to prescribe effective targeted therapies and personalized treatment plans for improved patient outcomes.
Scientific name: HER2/neu Protein Overexpression (IHC) Test
An immunohistochemistry (IHC) test used to measure HER2 protein levels in tumor samples, particularly in breast and gastric cancers, to determine eligibility for specialized targeted and biological therapies.
Service type
Histopathology Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Tissue sample processing
- Immunohistochemical staining
- Microscopic examination
- Detailed medical report
Medical Service Information
Target Groups
- Patients newly diagnosed with breast cancer.
- Patients with gastric or gastroesophageal junction cancer.
- Recurrent cancer cases to re-evaluate protein status.
Understanding Your Results
- Score 0 or 1+: Considered HER2-negative.
- Score 2+: Considered equivocal (requires further FISH testing).
- Score 3+: Considered HER2-positive (eligible for targeted therapy).
Conditions & Notices
- Previous biopsy sample or new biopsy required
- Provide previous medical reports related to the tumor
Medical services you might also like
